Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
SLC16A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
Invitae United States | 173 | 119 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics, part of Exact Sciences United States | 106 | 83 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
Baylor Genetics United States | 842 | 637 |
|
Comprehensive panel of monogenic diabetes. 28-gene NGS panel. Genologica Medica Spain | 60 | 28 |
|
Hypoglycemia, hyperinsulinism, and ketone metabolism panel. NGS panel of 50 genes. Genologica Medica Spain | 73 | 50 |
|
Glycogen Storage Disorders Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 40 | 32 |
|
Asper Biogene Asper Biogene LLC Estonia | 31 | 12 |
|
SLC16A1 Sequence Analysis (Prenatal Sequence Analysis) Baylor Genetics United States | 1 | 1 |
|
Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 10 | 10 |
|
Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 11 | 13 |
|
Al Jalila Children's Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 17 | 17 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Fulgent Genetics United States | 71 | 53 |
|
Invitae Ketolysis Disorders Panel Invitae United States | 7 | 3 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.